Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma and central nervous system vasculitis.

R Pathak1, A J Gabor

  • 1Department of Neurology, University of California, Davis, Sacramento.

Stroke
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis.

Nature cell biology·2025
Same author

Nail Changes Following Valproate Therapy.

Kathmandu University medical journal (KUMJ)·2024
Same author

DENTAL CAVITIES IN PEOPLE WITH TYPE 2 DIABETES MELLITUS: AN ANALYSIS OF RISK INDICATORS.

Georgian medical news·2024
Same author

Decellularized xenogenic bone graft for repair of segmental bone defect in rabbits.

Iranian journal of veterinary research·2023
Same author

Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1-2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting?

Indian journal of surgical oncology·2021
Same author

Diagnostic utility of ultrasonography and computerized tomography in gall bladder perforation: A case report.

Radiology case reports·2020
Same journal

ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

Stroke·2026
Same journal

Menopause and Its Implications for Stroke in Women.

Stroke·2026
Same journal

Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods Study.

Stroke·2026
Same journal

Aspirin for Stroke Primary Prevention: A Step Toward Genetic-Driven Personalized Medicine.

Stroke·2026
Same journal

Cognition After Stroke: It Is a Long Story.

Stroke·2026
Same journal

Emerging Therapy Critique: Glibenclamide for Cerebral Edema-A Semi-CHARMed Treatment.

Stroke·2026
See all related articles

Scleroderma patients can develop central nervous system vasculitis, even without systemic disease. Aggressive immunosuppressive therapy effectively reversed neurological symptoms in a CREST syndrome patient.

Area of Science:

  • Neurology
  • Rheumatology
  • Immunology

Background:

  • Scleroderma, particularly the CREST syndrome variant, is associated with potential neurological complications.
  • Central nervous system (CNS) vasculitis is a rare but serious manifestation that can affect patients with connective tissue diseases.

Observation:

  • A patient with scleroderma (CREST syndrome) presented with symptoms suggestive of CNS vasculitis.
  • Angiography revealed characteristic segmental arterial narrowing, indicative of vasculitis.
  • Leptomeningeal biopsy results were notably normal, challenging typical diagnostic criteria.

Findings:

  • The patient showed no signs of systemic vasculitis, renal failure, or malignant hypertension, conditions often presumed necessary for CNS dysfunction in scleroderma.
  • Despite normal biopsy findings, the clinical presentation and angiography strongly supported CNS vasculitis.

Related Experiment Videos

  • Neurological signs and symptoms associated with vasculitis demonstrated significant improvement.

    • Implications:

    • This case expands the understanding of CNS vasculitis presentation in scleroderma, highlighting that systemic involvement is not always a prerequisite.
    • It suggests that aggressive immunosuppressive therapy can be a successful treatment modality for CNS vasculitis in scleroderma patients, even with atypical diagnostic findings.
    • Further research into the pathogenesis and diagnostic markers of CNS vasculitis in scleroderma is warranted.